ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $44,371,000 | -27.0% | 2,133,222 | +15.0% | 0.01% | -33.3% |
| Q3 2016 | $60,787,000 | +38.8% | 1,854,944 | +5.7% | 0.01% | +20.0% |
| Q2 2016 | $43,810,000 | +57.4% | 1,754,513 | +54.3% | 0.01% | +66.7% |
| Q1 2016 | $27,841,000 | -22.7% | 1,136,823 | +4.2% | 0.01% | -25.0% |
| Q4 2015 | $36,033,000 | -6.3% | 1,090,915 | -7.0% | 0.01% | -20.0% |
| Q3 2015 | $38,449,000 | -25.8% | 1,173,654 | +19.9% | 0.01% | -16.7% |
| Q2 2015 | $51,838,000 | +138.0% | 978,637 | +29.7% | 0.01% | +140.0% |
| Q1 2015 | $21,777,000 | +28.3% | 754,562 | +29.3% | 0.01% | +25.0% |
| Q4 2014 | $16,976,000 | +608.2% | 583,582 | +208.7% | 0.00% | +300.0% |
| Q3 2014 | $2,397,000 | -39.3% | 189,069 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $3,952,000 | – | 196,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |